# OnCo record actuate-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/actuate-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "actuate-therapeutics" ;
  schema:name "Actuate Therapeutics"@en ;
  schema:description "A Texas biotech developing elraglusib, a GSK-3 beta inhibitor that improved survival in a randomised phase 2 in metastatic pancreatic cancer."@en ;
  schema:url <https://onco.cc/companies/actuate-therapeutics/>, <https://www.actuatetherapeutics.com> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.actuatetherapeutics.com> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/ewing-sarcoma/> ;
  onco:drugs <https://onco.cc/drugs/elraglusib/> .